Becton Dickinson cash flow statement
In fiscal 2025, Becton Dickinson's operations generated $3.43bn of cash; it spent $760m on capital projects, leaving free cash flow of $2.67bn. It returned $1.20bn in dividends and $1.00bn through buybacks.
Cash flow statement
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,658 | 1,587 | 1,638 | 1,693 | 1,717 | 1,746 | 1,730 | 2,559 | 2,550 | 2,865 | 3,330 | 3,539 | 4,647 | 2,471 | 2,990 | 3,844 | 3,430 | 3,956 |
| Depreciation and amortisation | 465 | 491 | 494 | 511 | 546 | 562 | 891 | 1,114 | 1,088 | 1,978 | 2,253 | 2,115 | 2,230 | 2,229 | 2,288 | 2,286 | 2,462 | 2,497 |
| Stock-based pay | 87 | 79 | 73 | 89 | 100 | 113 | 166 | 196 | 174 | 322 | 261 | 236 | 229 | 233 | 259 | 247 | 258 | 283 |
| Capital spending | 585 | 531 | 509 | 487 | 522 | 592 | 596 | 693 | 727 | 895 | 957 | 769 | 1,194 | 973 | 874 | 725 | 760 | 753 |
| Free cash flow | 1,073 | 1,056 | 1,129 | 1,206 | 1,195 | 1,154 | 1,134 | 1,866 | 1,823 | 1,970 | 2,373 | 2,770 | 3,453 | 1,498 | 2,116 | 3,119 | 2,670 | 3,203 |
| Free cash flow after stock pay | 987 | 977 | 1,056 | 1,117 | 1,095 | 1,041 | 968 | 1,670 | 1,649 | 1,648 | 2,112 | 2,534 | 3,224 | 1,265 | 1,857 | 2,872 | 2,412 | 2,920 |
| Dividends paid | 317 | 346 | 361 | 368 | 386 | 421 | 485 | 562 | 677 | 927 | 984 | 1,026 | 1,048 | 1,082 | 1,114 | 1,100 | 1,196 | 1,172 |
| Share buybacks | 550 | 750 | 1,500 | 1,500 | 450 | 400 | 0 | 0 | 220 | 0 | 0 | 0 | 1,750 | 500 | 0 | 500 | 1,000 | 2,500 |
| Shares issued | — | — | — | — | — | — | 0 | 0 | 4,827 | 0 | 0 | 2,917 | 0 | 0 | — | — | — | — |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,178 | 693 | −204 | 1,089 | 1,852 | 657 | 671 | 776 |
| Depreciation and amortisation | 586 | 607 | 567 | 575 | 756 | 614 | 563 | 564 |
| Stock-based pay | 51 | 90 | 41 | 48 | 79 | 91 | 58 | 55 |
| Capital spending | 296 | 105 | 114 | 164 | 377 | 108 | 125 | 143 |
| Free cash flow | 882 | 588 | −318 | 925 | 1,475 | 549 | 546 | 633 |
| Free cash flow after stock pay | 831 | 498 | −359 | 877 | 1,396 | 458 | 488 | 578 |
Compare with peers
- GE HealthCare cash flow
- Boston Scientific cash flow
- Stryker Corporation cash flow
- Koninklijke Philips NV cash flow
- Medtronic cash flow
Head to head: BDX vs GEHCBDX vs BSXBDX vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies